Tag

News

20/08/2018

Hong Kong, Pakistan and Vietnam Hit By Dengue Fever.

It’s time for another Dengue travel update. So what has changed? Travelling to a tropical part of the world? Then Dengue may be a problem for you. We produced a blog some years ago on the disease, how is spread and what you can do to prevent it.  The disease hasn’t changed in this time and neither have the destinations, but the purpose of this is to highlight ongoing outbreaks: Hong Kong The current outbreak in Lion Rock Park.  Lion Rock Park is a popular destination on the edge of... Read More

17/01/2018

NEWS: Sanofi Reimburse Unused Dengue Fever Vaccines

Sanofi set to reimburse the Philippines Government for unused doses of a new Dengue Fever vaccine. The worlds first dengue vaccine Dengvaxi (CDT-TDV) by Sanofi Pasteur was registered in Mexico in December 2015. It was indicated for nationals living in areas with high disease burden between the ages of 9-45 years of age. The product has passed many clinical trials worldwide and is registered for use with 19 regulatory authorities worldwide. Two of these authorities, Brazil and the Philippines, introduced the vaccine into subnational programmes, targeting approximately 1 million individuals.... Read More

16/01/2018

NEWS: Yellow Fever in Brazil – UPDATE

We have an update on the Yellow Fever situation in Brazil. Earlier last year, we published an article on Yellow Fever which was prompted by an uncontrolled outbreak in Brazil. The outbreak was affecting states including Rio de Janeiro and Sao Paulo. Whilst the outbreak appeared to be under control in July 2017, new cases have arisen in Sao Paulo state leading to 4 deaths with another 92 cases currently under investigation. In an attempt to curb the spread of the deadly virus, a mass immunisation campaign is due to... Read More

15/01/2018

NEWS: New Conjugate Typhoid Vaccine Is Awarded WHO Prequalification

WHO to take a big step forward in the fight against Typhoid. An Indian bioresearch company has now been granted World Health Organisation pre-qualification for their product Typbar-TCV.  Typbar-TCV is a conjugate vaccine.  Conjugate vaccines offer longer and stronger immunity over their polysaccharide cousins and its product has been demonstrated safe in populations as young as 6 months. Until now countries endemic with Typhoid fever, which is a bacterial infection caused by Salmonella, have relied on an old polysaccharide vaccine.  The current polysaccharide vaccine can only be used from 2... Read More

12/01/2018

NEWS: WHO Supports Immunisation Against Cholera In Zambia

Following an outbreak of cholera in Zambia’s capital, 1 million residents of Lusaka are set to be immunised against the deadly disease. The outbreak initially started in the Chipata sub-district on the 2nd October 2017, where it continued to spread leading to the Minister of Health to declare an outbreak on the 6th October¹. On the 9th of January 2018, the Zambian Government placed a temporary suspension on the issue of passports and national identity cards in a bid to contain the disease².  It is only now that the Zambian government... Read More

11/01/2018

NEWS: Bill Gates To Repay Nigeria’s Polio Debt

The Bill and Melinda Gates Foundation is set to repay Nigeria’s $76m Polio debt! Nigeria has authorised the gates foundation, run by Bill and Melissa Gates, to start repaying Nigeria’s Overseas Development Assistance, which has helped Nigeria eradicate polio. The debt to be repaid is $76 million which is repayable to the Japanese government¹ The project’s aim was to eradicate polio in Nigeria by procuring enough vaccine to inoculate all children under 5 years of age a total of 476 million doses². The loan deal that was signed in 2014... Read More